MGRX Biotechonolgy IPO LONG
MGRX a recent IPO produces a med for erectile dysfunction without FDA approval;
They are basically selling a generic version of an approved medication and bypassing
the patent protections and betting they will fly under the regulator radar apparatus.
As might be expeted this recent nano-IPO is highlly volatile. Play with it only
if you have the requisite skills to do so and only with risk capital.
it does the marketing through direct to consumer telehealth services.
>>>>>>>>>>>>>>>>>>See also the link below <<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<
On review and analysis on the 30 minute chart, the price action is squeezing
down in a flat bottom triangle likely setting up a breakout upside.
The RSI oscillator shows RSI crossing 50% from below.
Volatility is compressing down inside the triangle for a squeeze set up.
Targets are based on the supply and demand zones of the Luxalgo indicator.
The first parget is the midline between the zones while the final target
is just below the supply zone. As can be seen on the chart, the first target
is about 100% upside while the final target is 200% upside. One of the
position is closed at each target making the return 150% overall.
Stop loss is below the demand zone. A stop loss is 15% yields an overall
reward to risk ration of 10:1.
They are basically selling a generic version of an approved medication and bypassing
the patent protections and betting they will fly under the regulator radar apparatus.
As might be expeted this recent nano-IPO is highlly volatile. Play with it only
if you have the requisite skills to do so and only with risk capital.
it does the marketing through direct to consumer telehealth services.
>>>>>>>>>>>>>>>>>>See also the link below <<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<
On review and analysis on the 30 minute chart, the price action is squeezing
down in a flat bottom triangle likely setting up a breakout upside.
The RSI oscillator shows RSI crossing 50% from below.
Volatility is compressing down inside the triangle for a squeeze set up.
Targets are based on the supply and demand zones of the Luxalgo indicator.
The first parget is the midline between the zones while the final target
is just below the supply zone. As can be seen on the chart, the first target
is about 100% upside while the final target is 200% upside. One of the
position is closed at each target making the return 150% overall.
Stop loss is below the demand zone. A stop loss is 15% yields an overall
reward to risk ration of 10:1.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.